scispace - formally typeset
L

Long Zhang

Researcher at Life Sciences Institute

Publications -  1142
Citations -  28760

Long Zhang is an academic researcher from Life Sciences Institute. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 63, co-authored 670 publications receiving 20575 citations. Previous affiliations of Long Zhang include University of Nebraska Medical Center & Nanjing University of Aeronautics and Astronautics.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

A systematic review of SARS-CoV-2 vaccine candidates.

TL;DR: An overview of the experimental and clinical data obtained from recent SARS-CoV-2 vaccines trials are provided, and certain potential safety issues that require consideration when developing vaccines are highlighted.
Journal ArticleDOI

Observation of a Near-Threshold ωJ/ψ Mass Enhancement in Exclusive B→KωJ/ψ Decays

Suyong Choi, +147 more
TL;DR: In this paper, the authors presented a method to solve the problem of the EPT problem in PhysRevLett, a journal published on 2010-11-05, modified on 2017-12-10.
Journal ArticleDOI

Bearing fault diagnosis using multi-scale entropy and adaptive neuro-fuzzy inference

TL;DR: Experimental results indicate that the proposed approach cannot only reliably discriminate among different fault categories, but identify the level of fault severity, so the approach has possibility for bearing incipient fault diagnosis.
Journal ArticleDOI

USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor

TL;DR: USP4 is uncovered as an important determinant for crosstalk between TGF-β and AKT signalling pathways and is found to directly interact with TβRI and act as a deubiquitylating enzyme, thereby controlling T βRI levels at the plasma membrane.